LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

ProShare Advisors LLC's Holding History (CIK: 0001357955)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 38,865 Value ($000) $18 Avg Close $0.59 Range $0.45 - $0.75
Q4 2024
Shares 41,606 Value ($000) $21 Avg Close $0.73 Range $0.48 - $0.97
Q3 2024
Shares 27,915 Value ($000) $25 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 17,774 Value ($000) $18 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 23,841 Value ($000) $35 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 21,964 Value ($000) $24 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 16,766 Value ($000) $20 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 16,784 Value ($000) $24 Avg Close $1.38 Range $1.24 - $1.57
Q1 2022
Shares 23,513 Value ($000) $36 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 27,397 Value ($000) $67 Avg Close $2.34 Range $1.80 - $2.71
Q3 2021
Shares 16,071 Value ($000) $40 Avg Close $2.57 Range $2.26 - $2.90
Q2 2021
Shares 31,459 Value ($000) $90 Avg Close $2.59 Range $2.14 - $3.00
Q4 2019
Shares 14,661 Value ($000) $13 Avg Close $0.83 Range $0.53 - $1.02
Q3 2019
Shares 12,318 Value ($000) $12 Avg Close $1.03 Range $0.82 - $1.26